DIGITAL EDITION

ARCHIVES

Category: Topics

Prescription Monitoring Programs: To Use or Not to Use

by Kathryn E. Heagerty, BSN, JD Professional Risk Management Services, Inc., Arlington, VA Innov Clin Neurosci. 2013;10(11–12):28–30

Letter to the editor: Buprenorphine/ Naloxone Treatment in the Correctional Setting—Use or Misuse

Dear Editor: Over 50 percent of the incarcerated population in the United States have a history substance abuse, and it has been noted that over 200,000 of the incarcerated population

Abstracts of Poster Presentations CNS Summit 2013

November 14–17, 2013 Boca Raton, Florida Innov Clin Neurosci. 2013;10(11–12 Suppl B):1–18

A Case of Reversible Neuropsychiatric Symptoms in HIV due to Toxic Leukoencephalopathy

by Michelle C. Liu, BA; Amir Garakani, MD; Katherine A. Krauskopf, MD, MPH; and Jessica Robinson-Papp, MD Ms. Liu is from the Icahn School of Medicine at Mount Sinai, New

Obesity and Substance Misuse: Is There a Relationship?

by Randy A. Sansone, MD, and Lori A. Sansone, MD R. Sansone is a professor in the Departments of Psychiatry and Internal Medicine at Wright State University School of Medicine

Managing Handoff Risk in Psychiatry

by Charles D. Cash, JD, LLM Mr. Cash is the Vice President of Risk Management at PRMS, Inc. in Arlington, Virginia. Innov Clin Neurosci. 2013;10(7–8):25–27